Current Practice in ADHD
Updates in the research and clinical practice for ADHD across the lifespan
Attention-Deficit/Hyperactivity Disorder (ADHD) is a prevalent and impairing neurodevelopmental disorder that affects individuals across the lifespan. While historically viewed as a childhood disorder, growing evidence supports its persistence into adolescence and adulthood. Despite extensive research, clinicians often face challenges in accurate diagnosis, differentiation from comorbid conditions, and implementation of evidence-based treatments. Additionally, recent advancements in pharmacologic and non-pharmacologic therapies, as well as updates to diagnostic criteria and practice guidelines, necessitate that clinicians keep abreast of best practices to ensure successful outcomes in patient care.
This course aims to address common clinical challenges via updates from international experts. Faculty will discuss diagnostic complexities, the latest pharmacologic and non-pharmacologic treatment options, effective management of comorbid conditions, and population differences in symptom presentation. Participants will gain up-to-date knowledge and tools to immediately implement with their patients.
*Generative AI was used to draft this overview; the course director then reviewed and edited it to ensure clinical accuracy.
Upon completion of this activity, participants will be able to:
Apply updated diagnostic criteria and tools for identifying ADHD across different age and population groups
Evaluate current pharmacologic treatments, including emerging therapies, for ADHD management
Integrate non-pharmacologic approaches and behavioral interventions into individualized treatment plans
Discuss the interplay of ADHD and autism and develop strategies to address features of both conditions in clinical care
Summarize the prevalence of ADHD co-occurring with mood disorders, and current guidelines for starting and managing treatment
Describe the assessment and management of sleep disorders in patients with ADHD
Explain how ADHD manifests differently in women and girls
Here's what previous learners had to say!
“Very engaging speakers. Content moved at a good pace, was embedded with anecdotes to both aid in memory and illustrate concepts. Slides were concise and supportive (I couldn't have obtained all the info just from the slides).”
“Every one of these presentations was valuable on its own terms and in sync with the overall learning objectives.”
“Every single speaker had relevant, up to date and informative information--that was delivered well. I've never attended a conference where this has been the case before! The presenters were fantastic and the issues were well represented.”
Margaret Weiss, MD, PhD, FRCP(C) (Course Director)
Director, Neurodevelopmental Clinic and Director of Clinical Research in Child Psychiatry, Cambridge Health Alliance/Cambridge Hospital; Associate Professor of Psychiatry, Harvard Medical School
Oscar Bukstein, MD, MPH
Associate Director, Faculty Development, Department of Psychiatry and Behavioral Sciences, Boston Children's Hospital; Professor of Psychiatry, Harvard Medical School
Greg Mattingly, MD
Associate Clinical Professor, Washington University St. Louis; President, American Professional Society of ADHD and Related Disorders (APSARD); Founding partner, St. Charles Psychiatric Associates; Principal Investigator, Midwest Research Group
Kathleen Nadeau, PhD
Center Director and Founder, The Chesapeake Center, Bethesda, MD
Mary Solanto, PhD
Clinical Psychologist; Professor of Pediatrics and Psychiatry, Zucker School of Medicine at Hofstra-Northwell; Division of Developmental and Behavioral Pediatrics, Department of Pediatrics, Cohen Children’s Medical Center of New York
Mark Stein, PhD, ABPP
Professor of Psychiatry and Behavioral Science and Professor of Pediatrics, University of Washington; Founder, PEARL Clinic/ADHD and Related Disorders Program, Seattle Children's Hospital
Robyn Thom, MD
Psychiatrist, Lurie Center for Autism, MassGeneral Hospital for Children; Assistant Professor, Harvard Medical School
Psychologists: Cambridge Health Alliance, Division of Continuing Education in Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. Cambridge Health Alliance, Division of Continuing Education in Psychiatry maintains responsibility for this program and its content. This course offers 7.25 continuing education credits.
Social Workers: Cambridge Health Alliance, Division of Continuing Education in Psychiatry is recognized by the New York State Education Department's State Board for Social Work as an Approved Provider #0038 of continuing education for licensed social workers. This course offers 7.25 contact hours. Social workers from other states should check with their individual board to confirm credit reciprocity with NY.
Counselors: Cambridge Health Alliance, Division of Continuing Education in Psychiatry has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5444. Programs that do not qualify for NBCC credit are clearly identified. Cambridge Health Alliance, Division of Continuing Education in Psychiatry is solely responsible for all aspects of the program. This course meets the requirements for 7.25 continuing education hours.